SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 325 filers reported holding SAREPTA THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.84 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $7,415,149 | -40.8% | 61,171 | -44.0% | 0.08% | -31.7% |
| Q2 2023 | $12,519,326 | -60.4% | 109,320 | -52.3% | 0.12% | -63.3% |
| Q1 2023 | $31,582,780 | -6.9% | 229,143 | -12.4% | 0.33% | -11.4% |
| Q4 2022 | $33,910,827 | +8.0% | 261,698 | -7.8% | 0.37% | +0.3% |
| Q3 2022 | $31,388,000 | -6.5% | 283,950 | -36.6% | 0.37% | -4.9% |
| Q2 2022 | $33,588,000 | -13.0% | 448,080 | -9.3% | 0.39% | +10.9% |
| Q1 2022 | $38,591,000 | -22.7% | 493,996 | -10.9% | 0.35% | -11.6% |
| Q4 2021 | $49,917,000 | -14.7% | 554,323 | -12.4% | 0.40% | -14.1% |
| Q3 2021 | $58,510,000 | +22.3% | 632,679 | +2.8% | 0.46% | +31.1% |
| Q2 2021 | $47,855,000 | +182.5% | 615,580 | +169.2% | 0.35% | +185.4% |
| Q1 2018 | $16,940,000 | – | 228,640 | – | 0.12% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sonic Fund II, L.P. | 112,689 | $14,541,000 | 14.93% |
| Casdin Capital, LLC | 670,000 | $86,457,000 | 7.95% |
| Logos Global Management LP | 226,002 | $29,163,000 | 7.19% |
| Avoro Capital Advisors LLC | 1,760,000 | $227,110,000 | 6.67% |
| Camber Capital Management LP | 600,000 | $77,424,000 | 3.94% |
| STANSBERRY ASSET MANAGEMENT, LLC | 71,133 | $9,179,000 | 3.74% |
| Eventide Asset Management | 996,000 | $128,524,000 | 3.62% |
| CADIAN CAPITAL MANAGEMENT, LP | 550,000 | $70,972,000 | 3.14% |
| RTW INVESTMENTS, LP | 605,762 | $78,168,000 | 2.95% |
| Consonance Capital Management LP | 356,145 | $45,957,000 | 2.80% |